Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars
Status:
Completed
Trial end date:
2017-11-23
Target enrollment:
Participant gender:
Summary
This is a multi-centre, randomized, investigator blinded, vehicle controlled trial using
intra-individual comparison (right half-face versus left half-face).
Subjects will have each half-face randomized to one of the two following treatments:
- Adapalene 0.3% - BPO 2.5% gel (TactuPump® Forte).
- Vehicle gel
The main objective of this trial is to evaluate the effect of Adapalene 0.3% - benzoyl
peroxide (BPO) 2.5% gel versus vehicle gel on the risk of formation of atrophic acne scars in
moderate to severe acne subjects.